NIH-funded research Sbir 2 grant

New small molecule to enhance dental implant integration with bone

Official title: Novel Small Molecule for Improved Dental Implant Osseointegration

Funded at Cayman Chemical Company, INC. · NIH-10489776 · Data updated 2026-11-12

This study is testing a new medicine that could help people with weak bones, like those with osteoporosis, get dental implants that fit better and last longer.

More Dental Implant research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionCayman Chemical Company, INC.
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 16, 2021
Project endAugust 31, 2025
Funding year2022
Award (this year)$906,661
NIH project number5R44DE030370-02
Project IDNIH-10489776 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with missing teeth who have low bone density or osteoporosis and are considering dental implants.

Less likely to help

Patients with healthy bone density and no history of dental implant failure are unlikely to benefit from this research.

What this research studies

This research investigates a novel small molecule designed to improve the integration of dental implants into the jawbone, particularly for patients with bone density issues like osteoporosis. The approach involves using a specific compound that has shown promise in laboratory settings for promoting bone regeneration and enhancing the mechanical stability of implants. By focusing on patients who may struggle with traditional implants due to bone density challenges, this research aims to provide a more effective solution for dental restoration. The study will involve both laboratory testing and clinical trials to assess the efficacy of the compound in human subjects.

Why it matters

Potential benefit: If successful, this research could lead to improved dental implant outcomes for patients with compromised bone density, reducing the risk of implant failure.

How similar studies have gone: Previous research has shown success with similar approaches in enhancing bone regeneration, making this a promising area of investigation.

Where this research is happening

  • Cayman Chemical Company, INC.
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Morano, Maria Ines — Cayman Chemical Company, INC.
  • Study coordinator: Morano, Maria Ines

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.